We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Nephrogenic systemic fibrosis is found only among gadolinium-exposed patients with renal insufficiency: a case-control study from Denmark.
- Authors
Elmholdt, T.R.; Pedersen, M.; Jørgensen, B.; Søndergaard, K.; Jensen, J.D.; Ramsing, M.; Olesen, A.B.
- Abstract
Summary Background Nephrogenic systemic fibrosis (NSF) is a systemic fibrosing disease associated with exposure to gadolinium-based contrast agents (GBCA) in patients with renal insufficiency. Objectives To report the prevalence of NSF in a well-defined cohort of patients with renal insufficiency exposed to GBCA, to investigate if GBCA-unexposed controls showed signs of NSF and to evaluate selected risk factors among NSF cases and GBCA-exposed controls. Methods A study among GBCA-exposed patients with renal insufficiency ( n = 565) was conducted to identify cases of NSF. The NSF cases found were age and sex matched and clinically compared with GBCA-exposed and unexposed patients with renal insufficiency in a case-control study. Results We identified 17 NSF cases. No signs of NSF were observed among the controls. The prevalence of NSF was 4·7%, highest among patients with chronic kidney disease (CKD) stage 5 exposed to GBCA and undergoing haemodialysis or peritoneal dialysis. Three NSF cases were identified among patients with CKD stage 3 and 4. Three patients developed NSF after macrocyclic GBCA exposure. NSF cases had a tendency to have higher serum phosphate concentrations than GBCA-exposed controls. Conclusions Our study supports the view that GBCA is a major risk factor for NSF. Importantly, we found that patients with CKD stage 3 and 4 can be at risk of NSF. NSF may also be triggered by macrocyclic GBCA. Further, we observed a trend for higher phosphate levels in NSF cases compared with controls. The important findings drawn from this case-control study indicate that NSF is not an overlooked condition among patients with renal insufficiency not exposed to GBCA.
- Subjects
DENMARK; FIBROSIS; GADOLINIUM; CHRONIC kidney failure; CASE-control method
- Publication
British Journal of Dermatology, 2011, Vol 165, Issue 4, p828
- ISSN
0007-0963
- Publication type
Article
- DOI
10.1111/j.1365-2133.2011.10465.x